Cutler Group LP Vir Biotechnology, Inc. Put Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 04, 2022	SELL	$19.08 - $26.7 $186,983 - $261,660	-9,800 Reduced 94.23%	600 $8,000
Q1 2022 Apr 14, 2022	BUY	$21.19 - $40.01 $42,380 - $80,020	2,000 Added 23.81%	10,400 $22,000
Q4 2021 Jan 18, 2022	BUY	$30.97 - $54.03 $257,051 - $448,449	8,300 Added 8300.0%	8,400 $29,000
Q1 2021 Apr 26, 2021	SELL	$26.34 - $83.07 $50,046 - $157,833	-1,900 Reduced 95.0%	100 $0
Q4 2020 Jan 21, 2021	SELL	$25.51 - $43.38 $28,061 - $47,718	-1,100 Reduced 35.48%	2,000 $14,000
Q3 2020 Oct 27, 2020	BUY	$28.28 - $53.6 $33,936 - $64,320	1,200 Added 63.16%	3,100 $32,000
Q2 2020 Jul 22, 2020	BUY	$27.89 - $47.86 $52,991 - $90,934	1,900 New	1,900 $5,000

219

87.4M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $944M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.